Subsequently, we conducted univariate COX regression analysis of variables potentially influencing the prognosis of ESCC patients, including age, gender, number of metastatic organs, ECOG score, number of immunotherapy lines, chemotherapy or targeted therapy combination, and baseline plasma IL-6 levels. The gene discussed is IL6; the disease is esophageal squamous cell carcinoma.